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ABSTRACT
Background Physical rehabilitation interventions aim
to ameliorate the effects of critical illness-associated
muscle dysfunction in survivors. We conducted an
overview of systematic reviews (SR) evaluating the effect
of these interventions across the continuum of recovery.
Methods Six electronic databases (Cochrane Library,
CENTRAL, DARE, Medline, Embase, and Cinahl) were
searched. Two review authors independently screened
articles for eligibility and conducted data extraction and
quality appraisal. Reporting quality was assessed and the
Grading of Recommendations Assessment, Development
and Evaluation approach applied to summarise overall
quality of evidence.
Results Five eligible SR were included in this overview,
of which three included meta-analyses. Reporting quality
of the reviews was judged as medium to high. Two
reviews reported moderate-to-high quality evidence of
the beneﬁcial effects of physical therapy commencing
during intensive care unit (ICU) admission in improving
critical illness polyneuropathy/myopathy, quality of life,
mortality and healthcare utilisation. These interventions
included early mobilisation, cycle ergometry and
electrical muscle stimulation. Two reviews reported very
low to low quality evidence of the beneﬁcial effects of
electrical muscle stimulation delivered in the ICU for
improving muscle strength, muscle structure and critical
illness polyneuropathy/myopathy. One review reported
that due to a lack of good quality randomised controlled
trials and inconsistency in measuring outcomes, there
was insufﬁcient evidence to support beneﬁcial effects
from physical rehabilitation delivered post-ICU discharge.
Conclusions Patients derive short-term beneﬁts from
physical rehabilitation delivered during ICU admission.
Further robust trials of electrical muscle stimulation in
the ICU and rehabilitation delivered following ICU
discharge are needed to determine the long-term impact
on patient care. This overview provides recommendations
for design of future interventional trials and SR.
Trial registration number CRD42015001068.
INTRODUCTION
The profound physical impairments associated with
critical illness are now increasingly recognised.
Acute peripheral skeletal muscle wasting and dys-
function occur rapidly during the early stages of
intensive care unit (ICU) admission1 2 and contrib-
ute to the development of ICU-acquired weakness
(ICU-AW). In the long-term, deﬁcits in physical
strength, functional performance and associated
health-related quality of life are evident in survivors
for many years following resolution of the original
illness.3–5
Rehabilitation is the cornerstone of management
of critical illness-related morbidity.6 Physical-based
rehabilitation interventions aim to ameliorate the
effects of ICU-AWand its sequelae, and are advocated
across the patient recovery continuum.7 Within the
ICU, physical rehabilitation typically centres around
early mobilisation encompassing a hierarchy of
increasingly functional activities,8 9 with potential
adjunctive technologies including electrical muscle
stimulation10 and cycle ergometry.11 Ward-based
management emphasises progression towards levels
of functional performance necessary to expedite hos-
pital discharge, which can be enhanced by coordi-
nated multidisciplinary therapy7 and input from
generic rehabilitation assistants.12 Following hospital
discharge, physical rehabilitation has been charac-
terised by delivery of either home-based or hospital-
based exercise rehabilitation programmes including
combined strength, cardiovascular and functional
components.13
Key messages
What is the key question?
▸ What physical rehabilitation interventions are
effective for patients during critical illness and
when are they best delivered?
What is the bottom line?
▸ Evidence conﬁrming physical rehabilitation
delivered in the early stages of critical illness in
the intensive care unit (ICU) produce
improvements in a range of outcomes is of
moderate-to-high quality, but there is
insufﬁcient evidence of effects from
interventions delivered post-ICU discharge.
Why read on?
▸ This overview comprehensively examines the
existing evidence for effectiveness of physical
rehabilitation in patients with critical illness
and provides informed recommendations for
future trial design and systematic review
conduct.
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The growing interest in physical rehabilitation for critical illness
patients has led to an exponential rise in the volume of published
data investigating effectiveness of interventions in recent years,
accompanied by multiple systematic reviews (SR) and
meta-analyses aiming to integrate available evidence and generate
conclusions on the most beneﬁcial therapeutic options. These
reviews include those focusing on delivery of physical rehabilita-
tion during the peri-ICU phase and also the subsequent recovery
stages post-ICU discharge. However while valuable, these individ-
ual SR are often restricted to a relatively narrow ﬁeld of question-
ing regarding a deﬁned ICU population, intervention, outcome
and timepoint. This speciﬁcity of focus precludes a broader over-
view of the existing evidence base for physical rehabilitation
during recovery from critical illness and limits translation of ﬁnd-
ings into clinical practice. Variability in review methodology and
quality may further inﬂuence robustness of any conclusions.
The aim of this review was to conduct an overview of existing
SR evaluating physical rehabilitation interventions for patients
with critical illness across the continuum of recovery. The over-
view speciﬁcally aimed to address the following questions:
1. At which stage of the recovery continuum do physical
rehabilitation interventions have the most effect?
2. Do particular patient populations gain more beneﬁt from
physical rehabilitation interventions than others?
3. Which type of physical rehabilitation interventions produce
beneﬁts (short-term and long-term) for post-critical illness
patients?
4. What adverse events or harmful effects are experienced
from receipt of any physical rehabilitation interventions?
METHODS
Protocol and registration
The protocol for this overview, modelled on the Cochrane
Collaboration approach14 and written using the Preferred
Reporting Items for Systematic review and Meta-Analysis
Procotol (PRISMA-P) guidelines,15 has been registered (National
Institute of Health Research International Prospective Register
of Systematic Reviews (PROSPERO) CRD42015001068, avail-
able at http://www.crd.york.ac.uk/PROSPERO/prospero.asp) and
published previously.16
Eligibility
SR were eligible if they included and summarised the results of
randomised controlled trials (RCTs) investigating the effect of
any physical rehabilitation intervention following critical illness
at any stage of the recovery continuum. Physical rehabilitation
intervention reviews were included if they addressed: (1) exercise
and/or mobility programmes for example, strengthening exercise
to target speciﬁc muscles or functional activities such as lying to
sitting over the edge of the bed, standing, stepping and walking;
(2) use of cycle ergometers involving upper or lower limb pedal-
ling at set levels of intensity or (3) the application of external
adjuncts such as electrical muscle stimulation to enable activation
of the muscle in patients unable to actively participate in rehabili-
tation. ‘Critical illness’ was deﬁned as patients admitted to the
ICU, irrespective of causal diagnosis but requiring invasive mech-
anical ventilation and multiorgan support. For reviews that
included both RCTs and non-RCTs, we included the review only
if we could extract the summary data from the RCTs. Further
detail can be found in the online supplementary section E1.
Data sources and search strategy
Data sources were searched as described in the protocol.16
There were no temporal or linguistic limitations applied and
initial searches were conducted on 3 April 2015 and rerun on
29 October 2015. Full search strategies are included in the
online supplementary section E2. There was no restriction on
publication year for inclusion.
Overview procedure
Following removal of duplicate and non-relevant material (BC),
two review authors (ﬁrst search BC, LS; rerun BC, BO’N) inde-
pendently screened search results based on abstract and title.
Full-text systematic review selection, data extraction, synthesis
and assessment of methodological quality within the overview
were conducted as described in the protocol.16 Bespoke eligibil-
ity assessment and data extraction forms are presented in the
online supplementary sections E3 and E4. Data extraction was
conducted independently by two authors (BO’N and LS); infor-
mation extracted included aims and rationale of the SR, stage of
recovery continuum covered, types of studies included, popula-
tion(s), intervention(s), comparator(s), primary and secondary
outcomes (where speciﬁed), ﬁndings (effect size including 95%
CI, results of pooling), date of last search and methods of
quality assessment. Outcome measures were further categorised
according to the WHO Classiﬁcation of Functioning Disability
and Health domains of ‘Impairment’, ‘Activity limitation’ and
‘Participation restriction’,17 with additional categories of
‘Adverse events/harms’ and ‘Healthcare utilisation’.
Quality of reporting and methodological quality of included
reviews were appraised independently by two authors (BC and
BB) using the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA)18 checklist and the Assessment of
Multiple Systematic Reviews (AMSTAR) tool19 (see online sup-
plementary section E5). The PRISMA checklist details criteria
for optimum reporting of SR across Title, Introduction,
Methods, Results, Discussion and Funding sections. The
AMSTAR tool assesses the appropriate conduct of SR, for
example, performance of duplicate study selection and data
extraction and provision of characteristics of included studies.
The Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach20 was used to assess overall
quality of evidence for the interventions evaluated in included
SR according to the outcomes identiﬁed. This approach assesses
elements of risk of bias (methodological conduct), inconsistency
(unexplained heterogeneity of results), indirectness (indirect
population, intervention, control or outcomes) and imprecision
(wide CIs) using the Cochrane Underlying Methodology.14
Where possible, we used information directly reported in the
SR otherwise we graded the evidence.
RESULTS
Search results
There were 8835 potentially eligible studies, with a further 8
articles identiﬁed through the authors’ personal libraries
(ﬁgure 1). Following de-duplication and removal of non-
relevant material, and abstract screening, a total of 30 articles
underwent full-text screening for inclusion. Twenty-two SR
were subsequently excluded (see online supplementary section
E6). Complete agreement between the two independent
reviewers was evident for eligibility of full-text articles (percent-
age agreement=100%, κ=1.0). Arbitration by a third reviewer
was not required. Three SR were further excluded during the
data extraction stage.21–23 No meaningful data could be
extracted from these reviews as they reported only a narrative
summary and did not include or synthesise the results from
included studies.
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Included systematic reviews and characteristics
Five SR were eligible for inclusion13 24–27 (table 1). Reviews
were published between 2013 and 2015, with the most recent
search date for included studies reported as 15 May 2014.13
A total of 24 relevant individual RCTs were included within the
ﬁve SR, ranging between 225 and 1026 overall (see online sup-
plementary section E7). Six RCTs overlapped across two of the
included SR, and two further additional RCTs overlapped
across three of the included SR. Three SR included a
meta-analysis: one review assessed the effect of early physical
rehabilitation and electrical muscle stimulation on the primary
outcome of incidence of critical illness polyneuropathy or
myopathy,25 one review assessed effect of physical therapy (mul-
tiple interventions) across a range of clinical outcomes26 and
one review did not specify their primary outcome, but assessed
the effect of neuromuscular electrical stimulation (NMES) on
quadriceps muscle strength.27 All reviews used an objective scale
to assess methodological risk of bias in their included studies.
Three SR focused solely on physical rehabilitation interven-
tions delivered within ICU.25–27 One review included all stages
of the recovery continuum,24 and another the post-ICU dis-
charge stage only.13 There was overall consistency across all ﬁve
SR with regard to target populations, which broadly centred on
adult patients who had been admitted to the ICU with critical
illness. However, individual SR reported varying levels of
summary detail for characteristics of included patient popula-
tions (see online supplementary section E8). Interventions
included physical or exercise-based therapy13 24–26 or NMES.27
Further detail of the included interventions described in
included SR is reported in the online supplementary section E9.
Outcome measures used to determine effectiveness of interven-
tions within RCTs of included SR varied considerably and only
Figure 1 Flow diagram summarising systematic review selection. OLS, online supplementary material; RCT, randomised controlled trial.
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Table 1 Characteristics of included systematic reviews
Author (year)
Aim of SR
Stage of
recovery
continuum
Search dates*
No. studies included
Patients included (range;
total) Population† Intervention Comparator
Category of outcome
Outcome measure/s (*denotes primary)
Quality appraisal
method
Kayambu et al (2013)26
Review the evidence base for
exercise in critically ill patients
In ICU 1980 to January 2012
10
24–140; 790
Patients receiving physical
therapy in the ICU
Physical therapy No or minimal physical
therapy in contrast to
the intervention group
Impairment:
Peripheral muscle strength
Respiratory muscle strength
Activity limitation: PFParticipation restriction:
Quality of life
Healthcare utilisation: Ventilator-free days
ICU and hospital LOS
Mortality
PEDro
Revised-AMSTAR
Hermans et al (2014)25‡
Review the evidence for any
intervention to reduce the
incidence of CIP or CIM in
critically ill individuals
In ICU 1966 to 4 October 2011
2
104–140; 244
Adult (≥18 years of age)
admitted to a medical, surgical
or mixed ICU
Physiotherapy
EMS
Rehabilitation
programme
Placebo, no treatment
or a different treatment
Impairment: Incidence of CIP/CIM in
ICU*Healthcare utilisation:
Duration of MV
ICU LOS
30d and 180d mortality
Adverse events:Serious adverse events
Cochrane Risk of
Bias
Wageck et al (2014)27
Investigate the applications
and effects of NMES in
critically ill patients in the ICU
In ICU Up until 26 November 2013
8
16–52; 274
Adult (≥18 years of age)
critically ill patients in the ICU
for ≥48 hours
NMES Not specified Impairment:
Muscle strength
Muscle structure
Healthcare utilisation:
ICU LOS
Duration MV
Adverse events:
Complications from immobilisation and bed rest
PEDro
Calvo-Ayala et al (2013)24§
Identify effective interventions
that improve long-term PF in
ICU survivors
Across all
stages
January 1990 to December
2012
7
16–195; 678
Inclusion
Adult (≥18 years of age) patients
admitted to an ICUExclusion
Acquired brain injury or
underlying neuropathy/myopathy
Long-term acute-care hospital
patients
Exercise/physical
therapy
Placebo, no treatment
or a different treatment
Activity limitation: Long-term PF or its
surrogates*
PEDro
Connolly et al (2015)13¶
Assess effectiveness of exercise
rehabilitation programmes
initiated after ICU discharge in
adult ICU survivors
Post-ICU
discharge
1966 to 15 May 2014
6
16–195; 483
Inclusion
Adult (≥18 years of age) patients
admitted to an ICU or critical
care unit; MV ≥24 hours
Discharged from ICU at the time
of receiving the
interventionExclusion
Palliative care
Patients with targeted
rehabilitation pathways
Exercise
rehabilitation or
training
Any other intervention,
control or ‘usual care’
programme
Activity limitation: Functional exercise
capacity*Participation restriction: Health-related
quality of life*Healthcare utilisation:
MortalityAdverse events: Adverse events
Cochrane Risk of
Bias
*Search dates reported as per individual systematic review and may/may not include specific detail.
†Population described as per individual systematic review and may/may not include specific ‘Inclusion’ and ‘Exclusion’ criteria.
‡SR includes any treatment related to decreasing risk of CIP/CIM; data reported relate to physical rehabilitation interventions included.
§SR includes any treatment where long-term PF was an outcome; data reported relate to physical rehabilitation interventions included.
¶NB include ‘Other’ outcomes related to trial intervention, for example, withdrawal rates, adherence and loss to follow-up.
AMSTAR, Assessment of Multiple Systematic Reviews; CIM, critical illness myopathy; CIP, critical illness polyneuropathy; EMS, electrical muscle stimulation; ICU, intensive care unit; LOS, length of stay; MV, mechanical ventilation; NMES, neuromuscular
electrical stimulation; PEDro, Physiotherapy Evidence Database; PF, physical function.
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three reviews speciﬁed their primary outcomes.13 24 25
Outcomes classiﬁed as reﬂecting ‘Impairment’17 tended to be
adopted in reviews, where interventions were delivered in the
ICU. Outcomes related to healthcare utilisation featured in four
out of the ﬁve reviews.13 25–27 Three SR reported adverse
events.13 25 27
Assessment of methodological quality of included
systematic reviews
Median (IQR) PRISMA and AMSTAR scores were 17.0 (16.5–
25.0)/27 and 7.0 (6.3–9.0)/11, respectively. Percentage agreement
between the two reviewers for scoring items on the PRISMA
checklist was 70.4 (66.7–85.2)% and 72.7 (59.1–81.8)% for
AMSTAR items. Any disagreements were resolved through con-
sensus and no additional reviewer was required for arbitration.
Two SR, scoring highest for PRISMA scores, also scored the great-
est AMSTAR scores and were classiﬁed as high quality;13 25 these
were both Cochrane reviews. Results are reported in table 2 and
online supplementary section E10.
When the individual sections of the PRISMA checklist were
analysed (Title, Abstract, Introduction, Methods, Results,
Discussion and Funding), the ‘Title’ section was most compre-
hensively completed across all included reviews (100%), and
‘Funding’ the least well completed (40%) (ﬁgure 2). Figure 3
presents the frequency of each AMSTAR item that was
addressed across the included SR. Items poorly completed were
publication of a priori protocols, consideration of publication
status as an inclusion criterion, assessment of publication bias
and declaration of conﬂicts of interest.
Findings of included systematic reviews
The main ﬁndings and conclusions from each included SR are
presented in the online supplementary section E11. Three SR
reported beneﬁts from delivery of early (during ICU) physical
rehabilitation interventions comprising a variety of exercise,
mobilisation, ergometry and muscle strengthening strategies24–26
(see online supplementary table E11). Outcomes were typically
short-term, for example, peripheral muscle strength at ICU dis-
charge, duration of mechanical ventilation, ICU length of stay
(see online supplementary table E14). However, due to the het-
erogeneity of individual study designs and intervention proto-
cols, it is not possible to specify a more precise therapeutic
prescription. One SR reported favourable effects from electrical
muscle stimulation.27 The only SR that focused on post-ICU dis-
charge rehabilitation was unable to conclude effectiveness of
any intervention.13 Only two SR evaluated adverse events asso-
ciated with physical rehabilitation interventions delivered in the
ICU and post-ICU discharge, and no serious adverse events
were reported.13 25 One review reported that delivery of elec-
trical muscle stimulation had no effect on prevention of
complications, but no other speciﬁc adverse events related to
the intervention itself were examined.27
GRADE summary of evidence
The summary of evidence is presented in table 3 for physical
therapy interventions and table 4 for NMES interventions con-
ducted in the ICU. We report the pooled effect sizes or other
data that were directly reported in the original SR. The GRADE
data extraction tables are provided in the online supplementary
section E12. For physical rehabilitation interventions delivered
in the ICU, there was high-quality evidence of effect for critical
illness polyneuropathy and myopathy (Impairment), quality of
life (Participation restriction) and ICU length of stay, hospital
length of stay and hospital mortality (Healthcare utilisation).
The quality of evidence for peripheral and respiratory muscle
strength and respiratory function was low. For NMES interven-
tions conducted in ICU, the quality of evidence for critical
illness polyneuropathy/myopathy and muscle structure was low
and for muscle strength was very low. As only one SR evaluated
physical therapy interventions in the post-ICU period, results
are reported according to the original SR13 (table 5). Quality of
evidence for outcomes was either low or very low.
DISCUSSION
The aim of this review was to conduct an overview of existing
SR to synthesise the current state of the evidence for physical
rehabilitation interventions for critically ill patients delivered
across the recovery continuum. We identiﬁed ﬁve SR for inclu-
sion of either high or moderate quality, three of which included
meta-analyses. The majority of reviews focused on interventions
delivered during the early stage of the recovery continuum
during ICU admission, with favourable effects from physical
exercise-based strategies and electrical muscle stimulation on
Table 2 Results for PRISMA and AMSTAR quality appraisal of included systematic reviews
Author PRISMA score (/27) PRISMA score (% of applicable) AMSTAR score (/11) AMSTAR score (% of applicable) AMSTAR quality grade
Kayambu et al26 17 68.0 6 54.5 Medium
Hermans et al25 25 96.2 10 90.9 High
Wageck et al27 17 70.8 6.5 54.5 Medium
Calvo-Ayala et al24 16 69.6 7 70.0 Medium
Connolly et al13 25 100 8 88.9 High
Summary 17.0 (16.5–25.0) 70.8 (68.8–98.1) 7.0 (6.3–9.0) 70.0 (54.5–89.9) –
Figure 2 Summary of PRISMA checklist section items reported across
all included reviews. PRISMA, Preferred Reporting Items for Systematic
Reviews and Meta-analyses.
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short-term outcomes. Only one review solely examined the
post-ICU discharge stage and was unable to demonstrate a
beneﬁt from interventions delivered at this time. While
overviews of SR have previously been conducted in other areas
of clinical practice, the current overview is novel and timely in
examining the evidence within the ﬁeld of rehabilitation during
critical illness, which has grown exponentially in recent years,
and which has the advantage of allowing comparison and con-
trast of individual reviews to provide a précis of evidence at
these different levels.28 Furthermore, we have been able to
establish recommendations for future interventional study
design and SR conduct.
Findings related to overview questions
Stage of the recovery continuum where physical interventions
have most effect
Our results support the ﬁndings for effectiveness of physical
rehabilitation interventions delivered during the ICU stay for
patients with critical illness. We would suggest that there is cur-
rently no requirement for further SR on physical interventions
Figure 3 Summary of completion of AMSTAR items across all
included reviews. For full AMSTAR item descriptors, see online
supplementary section E5. AMSTAR, Assessment of Multiple Systematic
Reviews.
Table 3 Summary of findings: intervention: physical rehabilitation; comparison: usual care
WHO domain
outcome
Review author; N studies:
N patients Pooled effect (95% CI)
GRADE of
evidence Explanation
Impairment
Peripheral muscle
strength
Kayambu et al26
2
244
Hedge’s g=0.27 (0.02 to 0.52), p=0.03 ϴϴ
Low*
Downgraded −2 for serious risk of bias
and imprecision
Respiratory muscle
strength
Kayambu et al26
2
105
Hedge’s g=0.51 (0.12 to 0.89), p=0.01 ϴϴ
Low†
Downgraded −2 for serious risk of bias
and imprecision
CIP/CIM Hermans et al25
1
104
RR 0.62 (0.39 to 0.96) p=0.03 ϴϴϴϴ
High
Activity limitation
Physical function‡ Kayambu et al26
2
143
Hedge’s g=0.46 (0.13 to 0.78), p=0.01 ϴϴ
Low§
Downgraded −2 for serious risk of bias
and imprecision
Participation restriction
Quality of Life Kayambu et al26
2
154
Hedge’s g=0.40 (0.08 to 0.71), p=0.01 ϴϴϴϴ
High
Healthcare utilisation
VFD Kayambu et al26
3
334
Hedge’s g=0.38 (0.16 to 0.59), p<0.001 ϴϴϴ
Moderate¶
Downgraded −1 for imprecision
ICU LOS Kayambu et al26
6
597
Hedge’s g=−0.34 (−0.51 to −0.18), p<0.001 ϴϴϴϴ
High
Hospital LOS Kayambu et al26 Hermans
et al25**
5
441
Hedge’s g=−0.34 (−0.53 to −0.15), p<0.001 ϴϴϴϴ
High
Hospital mortality Kayambu et al26 Hermans
et al25**
3
274
OR 1.0. (0.54 to 1.85) p=1.0 ϴϴϴϴ
High
Duration of MV Hermans et al25
1
Not reported
Median (IQR) 3.4 days (2.3 to 7.3) vs 6.1 days (4.0
to 9.6), p not reported
ϴϴϴ
Moderate††
Downgraded −1 for inadequate
reporting of effect
Stage of recovery: in the ICU.
*50% no random allocation; 50% no concealed allocation; 50% no blinded assessors; 50% not reported measures of key outcomes >85% patients and outcome was measured at
different end points.
†50% no concealed allocation; 50% no blinded assessors; 50% not reported measures of key outcomes >85% patients; 100% no ITT and unclear end point in one study.
‡Data from Kayambu et al,26 no pooled data reported in Calvo-Ayala et al.24
§50% no allocation concealment; 50% not reported measures of key outcomes >85% patients; 50% no ITT and outcome was measured at different end points.
¶Measured at different end points.
**Outcome from same RCT reported in both reviews.
††Inadequate reporting of effect.
CIP/CIM, critical illness polyneuropathy/myopathy; ICU, intensive care unit; ITT, intention to treat; LOS, length of stay; MV, mechanical ventilation; RCT, randomised controlled trials;
RR, risk ratio; VFD, ventilator-free days.
6 Connolly B, et al. Thorax 2016;0:1–10. doi:10.1136/thoraxjnl-2015-208273
Critical care
group.bmj.com on September 7, 2016 - Published by http://thorax.bmj.com/Downloaded from 
delivered within the ICU, until the existing evidence base is sup-
plemented by a volume of new trial data measuring functional
outcomes, for example, Moss et al29 or investigating electrical
muscle stimulation, an ‘in-ICU’ intervention that still requires
further evidence (table 6). Future studies would beneﬁt by
including long-term follow-up in addition to short-term assess-
ment. Further studies are required to evaluate physical rehabili-
tation interventions delivered post-ICU discharge including the
composition of such rehabilitation interventions. The review
focusing on this stage of recovery highlighted a number of out-
standing studies that were not included, but which would be
evaluated when fully published and included in a future update
of the review.13 The results of this may yet help to inform the
direction of post-ICU discharge rehabilitation research.
Patient populations gaining greater beneﬁt from physical
rehabilitation interventions
Included reviews were broadly consistent with regard to eligible
populations. However, the heterogeneity within the more
detailed patient characteristic data that each review reported
precluded us from identifying a speciﬁc population that gained
greater beneﬁt from physical rehabilitation interventions.
Identifying target populations that respond to speciﬁc interven-
tions may have positive impact on efﬁciency of rehabilitation
resource utilisation. Epidemiological studies may be of beneﬁt
to characterise patient cohorts that respond to different therap-
ies, for example, those with multiple comorbidities30 or demon-
strate particular features associated with ICU admission such as
a deﬁned duration of mechanical ventilation or degree of
muscle wasting.
Physical rehabilitation interventions producing short-term and/or
long-term beneﬁt
Physical rehabilitation and NMES interventions delivered early
during critical illness and ICU admission were found to be most
effective at improving short-term outcomes. In these instances,
initiation of intervention varied from within 72 hours of ICU
admission to between 7 and up to 30 days of mechanical venti-
lation delivery. However, the GRADE quality of evidence for
these outcomes was inconsistent and varied between very low
and high. One SR reported a beneﬁt on long-term physical func-
tion although interventions were commenced at varying stages
across the recovery continuum and the duration and timepoints
of follow-up were inconsistent across included studies.24 In the
future, deﬁning what constitutes early rehabilitation is vital to
facilitate interpreting the effects of interventions at this stage of
recovery.
Adverse events or harmful effects of physical rehabilitation
interventions
Only two reviews, one examining physical rehabilitation inter-
ventions within the ICU and the other post-ICU discharge,
reported adverse events. Based on ﬁndings from these reviews,
there appear to be minimal risks associated with delivery of
interventions. However, the majority of SR did not report this
outcome, either due to choice of outcome measure selection or
because none of the included studies within that review
reported these data. We strongly recommend that all future
RCTs report the frequency and nature of adverse events pertain-
ing to the intervention under examination or explicitly indicate,
if there were no adverse events. Furthermore, all future SR,
regardless of stage of the recovery continuum under investiga-
tion, should include the incidence of adverse events as an
outcome measure. Furthermore, we recommend that safety cri-
teria for commencing or stopping rehabilitation should be
reported to allow a more comprehensive review of methodology
to facilitate comparison in future RCTs and SR.
Critique of the overview method
This overview of SR represents a novel approach to synthesising
the existing evidence base of physical rehabilitation during crit-
ical illness. We adopted a number of strategies to strengthen our
review methodology. We developed a robust protocol, modelled
on the process outlined by the Cochrane Collaboration for
undertaking an overview of this kind14 and reported in line
with recent guidelines.15 This protocol was registered on an
international database (PROSPERO), and fully published a
priori.16 Our search strategies were comprehensive, and we
undertook duplicate screening, data extraction and quality
assessments. In addition to the validated AMSTAR instrument
for rating methodological quality,19 we further examined the
proportion of items reported by each systematic review from the
recommended PRISMA checklist,18 and applied the GRADE
approach20 to summarising the quality of evidence.
There are several potential limitations to our review. We only
included SR that included RCTs or where RCT ﬁndings were
Table 4 Summary of findings; intervention: NMES
WHO domain
outcome
Review author;
N studies:
N patients Pooled effect (95% CI)
GRADE of
evidence Explanation
Impairment
Muscle strength Wageck et al27
3
66
SMD 0.77, (0.13 to 1.40),
p=0.02
ϴ
Very low*
Downgraded −3 for serious risk of bias, inconsistency and
imprecision
Muscle structure Wageck et al27
6
Not possible to pool ϴϴ
Low†
Downgraded −2 for serious inconsistency and indirectness
CIP/CIM Hermans et al25
1
52
RR 0.32 (0.10 to 1.01), p=0.05 ϴϴ
Low‡
Downgraded −2 for serious risk of bias and indirectness
Comparison: usual care. Stage of recovery: in the ICU.
*50% no concealed allocation; 50% no blinded assessors; 50% not reported measures of key outcomes >85% patients; 50% no ITT and mean difference in one study does not fall
within the 95% CI of the other.
†Three studies reported an effect and three did not; and different outcome measures were used at different timepoints.
‡High ROB reported by review for this study vis-à-vis randomisation, concealment, incomplete outcome data and selective reporting; and not all participants were evaluable.CIP/CIM,
critical illness polyneuropathy/myopathy; ICU, intensive care unit; ITT, intention to treat; NMES, neuromuscular electrical stimulation; ROB, risk of bias; RR, risk ratio; SMD, standard
mean difference.
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reported distinctly from non-RCT ﬁndings. This was the most
common factor accounting for ineligibility and therefore con-
tributed to the volume of evidence we were subsequently able to
evaluate and base our conclusions on. To this end, we excluded
a number of recent SR in the ﬁeld, for example, studies by Parry
et al31 and Li et al.32 We acknowledge a large volume of obser-
vational cohort data investigating physical rehabilitation in crit-
ical illness exists; many of these data that echo our ﬁndings have
been reported in other SR that were also excluded.33 However,
RCT represent the most rigorous study design to evaluate the
effectiveness of an intervention and are the only data that can
contribute to meta-analyses. In addition, we found considerable
overlap between RCT evaluated in included and excluded SR in
this overview, and where RCT did not overlap, their ﬁndings
were in keeping with the results of the overview. By strictly
adhering to our overview design, we have been able to focus on
assimilating the ﬁndings from reviews where this was examined
and reported. Clear delineation of reporting of ﬁndings from
RCTs and observational study designs in a systematic review
would facilitate interpretation of conclusions based on the
Table 5 Summary of findings; intervention: physical rehabilitation
WHO domain
outcome
Review author;
N studies: N patients Pooled effect (95% CI)
GRADE of
evidence Explanation
Activity limitation
Functional
exercise capacity
Connolly et al13
6
483*
Unable to pool data due to variability in use of outcome
measures across individual studies
ϴ
Very low
Downgraded −3 due to variability in multiple
aspects of methodology across studies, risk
of bias and differences in data reporting
Participation restriction
Health-related
quality of Life
Connolly et al13
2
254*
Unable to pool data due to variability in use of outcome
measures across individual studies and small study
number
ϴ
Very low
Downgraded −3 due to variability in multiple
aspects of methodology across studies, risk
of bias and differences in data reporting
Healthcare utilisation
Mortality Connolly et al13
6
483
Unable to pool data due to variation in study design; no
deaths reported in two studies; no difference in
mortality rates between intervention and control groups
in remaining four studies
ϴϴ
Low
Downgraded −2 due to serious inconsistency
and imprecision
Adverse events
Non-mortality
adverse events
Connolly et al13
4
376
Three studies reported no adverse events; one study
reported no significant difference between groups for
adverse events (n=1 event only)
ϴϴ
Low
Downgraded −2 due to lack of reported data
from two studies and serious imprecision
Comparison: usual care. Stage of recovery: post-ICU discharge.
*Data reported are overall number of participants enrolled in each study. Multiple outcome measures were observed across studies with variable numbers of patients for each measure
according to each study.
ICU, intensive care unit.
Table 6 Recommendations and rationale for future research
Recommendation Rationale
Future interventional trial
Evidence Focus on NMES interventions delivered in the ICU or physical rehabilitation
interventions delivered after ICU discharge
The current evidence for these specific areas is currently low and/or insufficient.
Focusing on these topics would address gaps in the existing evidence base
Population Define target population to benefit from interventions Stratification of patient cohorts that would benefit from rehabilitation interventions
would streamline the rehabilitation pathway, greater efficiency of resource utilisation
and cost-effectiveness as well as delivering personalised care
Intervention Full and accurate reporting of intervention detail using Template for
Intervention Description and Replication checklist and guide44
Increase transparency of intervention delivered within the trial, improve reporting of
interventions in a systematic and structured manner, enhance interpretation of
findings
Comparison Accurate and detailed description of usual care or the comparative
intervention arm should be documented
Facilitate understanding of the clinical context in which the intervention was trialled,
and assist in interpretation of findings and determining generalisability
Outcomes When available, use one or more relevant COS, for example, Connolly
et al.45 In addition, ensure inclusion of a patient-reported outcome, long-term
outcomes to fully evaluate effect of physical rehabilitation interventions and report
adverse events or harms associated with the intervention
COS facilitate greater comparison across studies, pooling of datasets for
meta-analyses and clinical applicability of results. Patient-reported outcomes were
not evident from the current overview, and long-term follow-up was limited. Adverse
event rates are valuable for considering clinical efficacy of an intervention even if
statistically significant differences are observed
Timepoint Up-to-date literature search to underpin research question; further updated
at the time of trial publication
Ensure trial findings are reported in context of most current existing data
Publication of a priori trial protocol developed in line with Standard Protocol Items:
Recommendations for Interventional Trials guidance
Enhances credibility of final publication of trial findings by supplementing clinical
trial registration; streamlines final publication text; comprehensive reporting of key
trial components facilitates transparency
Include a process evaluation framework into trial design of complex interventions46 To distinguish true intervention effect from factors related to delivery of intervention
and trial conduct; explain contextual influences and provide insight into wider
implementation
COS, core outcome sets; ICU, intensive care unit; NMES, neuromuscular electrical stimulation.
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relative weight of evidence from each category. Furthermore, we
intended to appraise the quality of evidence at the level of each
systematic review and for that reason we did not retrieve data
from systematic review authors or primary RCTs included in
reviews. This is in keeping with guidance for overview
conduct,14 and as also evident in overviews from other clinical
topics.34
Our overview contains SR of varying methodological quality
in terms of reporting and conduct. While use of the PRISMA
checklist18 to quantify the quality of review reporting is not a
validated method, collecting these data along with AMSTAR
scores19 allowed us to identify the main areas of SR where
reporting detail was lacking. A more recent revised version of
the AMSTAR tool (AMSTAR-R) has been published that pro-
vides a greater level of criterion detail for each quality item,35
this updated scoring system does not provide thresholds to clas-
sify overall quality.36 Our adoption of the GRADE approach
was novel and important when developing our conclusions and
recommendations to address the relative quality of evidence.20
We reran our searches such that this overview is current as of
October 2015. However, due to the time-lag between the last
date of a search conducted in a systematic review and its publi-
cation, there is the potential for more recent RCTs to have been
published but not yet included in a systematic review. The
authors are aware of a number of such RCTs.12 29 37–40
Individual review of these publications was beyond the scope
and purpose of the current overview,14 and we have identiﬁed
the last search date of included SR for readers’ awareness of the
currency of ﬁndings. We acknowledge that at present the
volume of evidence for post-ICU discharge physical rehabilita-
tion is lacking with only one published SR, which in itself is a
limitation for this stage of recovery. That said, the aim of this
overview was to include SR across the recovery continuum.
Identifying that the post-ICU discharge phase requires greater
focus of attention in the design and conduct of future trials is
particularly important in the context of established critical care
research priorities.41 We are the authors of one of the included
SR.13 While our clearly deﬁned eligibility criteria ensure trans-
parent and justiﬁed inclusion of this review, and quality
appraisal and data extraction were performed independently, in
duplicate and using objective tools where applicable, it is pos-
sible that this introduces potential bias through insufﬁcient inde-
pendence when examining this review. That said, dual (co)
authorship is increasingly typical in the conduct of overviews
where expert authors may publish frequently in a particular
ﬁeld, and no standards have been agreed to comprehensively
address this issue.42 Furthermore, as a Cochrane review, this
review was subject to rigorous scrutiny during its conduct,
reporting and editorial process, and data extraction pertained
only to published data. Finally, due to the small number and
variation in included reviews, we were unable to perform the
intended subgroup and sensitivity analyses as planned in our ori-
ginal protocol.16
Recommendations for future research
The process of conducting this overview has informed a number
of suggested recommendations for consideration with regard to
the design and conduct of future trials of physical rehabilitation
interventions, which are outlined in relation to the Evidence,
Population, Intervention, Comparison, Outcome, Time stamp
framework43 (table 6). With regard future SR in this clinical
area, to ensure transparency of conduct we recommend these
should be prospectively registered on a relevant database in add-
ition to a priori publication of the full protocol in line with
recognised guidelines.15 If applicable, outcome data and quality
appraisal ﬁndings from RCT and non-RCT study designs should
be reported separately to enhance clarity of interpretation; RCT
data can contribute to meta-analyses and determine true effect-
iveness of an intervention. We recommend authors provide
completed PRISMA18 and AMSTAR19 checklists as online
supplementary material available for readers to encourage
greater robustness in the reporting and methodological appraisal
of reviews. In particular, based on the ﬁndings of this overview,
PRISMA items related to the Introduction, Methods, Discussion
and Funding sources, and AMSTAR items related to a priori
Design, Eligibility, Conclusions, Methods of meta-analysis,
Publication bias and Declaration of conﬂicts of interest should
be more comprehensively addressed. This overview also identi-
ﬁed Cochrane reviews as the highest quality. We would advise
future authors to adopt Cochrane methodology where possible
as a strategy to underpin review conduct and reporting.
CONCLUSION
This overview is the ﬁrst to synthesise the systematic review evi-
dence for physical rehabilitation interventions for patients with
critical illness across the recovery continuum. Our ﬁndings
conﬁrm evidence of beneﬁt in short-term outcomes from inter-
ventions delivered in the early stages of critical illness while in
the ICU, but there is currently no evidence to conclude beneﬁt
from interventions delivered post-ICU discharge. Quality of evi-
dence from these SR is inconsistent. We have made a number of
research recommendations for design and conduct of further
interventional trials and SR.
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